高级检索
当前位置: 首页 > 详情页

Preliminary discrimination and evaluation of clinical application value of ChatGPT4o in bone tumors

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Kunming Univ Sci & Technol, Med Coll, Kunming, Peoples R China [2]First Peoples Hosp Yunnan Prov, Dept Orthoped, Kunming, Peoples R China [3]Key Lab Digital Orthoped Yunnan Prov, Kunming, Peoples R China [4]Clin Med Res Ctr Orthoped & Sports Rehabil Yunnan, Kunming, Peoples R China [5]Clin Med Ctr Spinal Cord Dis Yunnan Prov, Kunming, Peoples R China [6]Kunming Univ Sci & Technol, Peoples Hosp Wenshan Prefecture, Affiliated Hosp, Wenshan, Peoples R China [7]Third Mil Med Univ, Army Med Univ, Xinqiao Hosp, Dept Urol,Urol Surg Ctr, Chongqing 400037, Peoples R China [8]First Peoples Hosp Yunnan Prov, Dept Pain, Kunming, Peoples R China
出处:
ISSN:

关键词: ChatGPT4o Clinical medicine Pathology Medical education

摘要:
Dear Editor 1. Introduction Radiographic imaging and pathological results are the two most critical methods for clinicians to distinguish between benign and malignant bone tumors. Fan Yang et al. [1] assessed the performance of ChatGPT3.5 in diagnosing benign and malignant bone tumors through imaging reports, highlighting the potential application of artificial intelligence (AI) technology in medical imaging diagnosis, particularly in enhancing diagnostic efficiency and reducing missed diagnoses. However, they did not evaluate the performance of ChatGPT in pathological images. To fill this gap, we evaluated the preliminary ability of ChatGPT4o in discerning bone tumors through pathological images and to optimize secondary prevention of malignant bone tumors in remote grassroots orthopedic settings. The study seeks to improve the diagnostic and treatment capabilities of remote grassroots doctors, assisting clinicians in early screening, diagnosis, and treatment. Additionally, it aims to ensure timely referral of patients to higher-level hospitals when constrained by objective conditions, thereby enhancing cancer cure rates and survival rates.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
JCR分区:
出版当年[2023]版:
Q2 ONCOLOGY
最新[2024]版:
Q2 ONCOLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版] 出版后一年[2024版]

第一作者:
第一作者机构: [1]Kunming Univ Sci & Technol, Med Coll, Kunming, Peoples R China [2]First Peoples Hosp Yunnan Prov, Dept Orthoped, Kunming, Peoples R China [3]Key Lab Digital Orthoped Yunnan Prov, Kunming, Peoples R China [4]Clin Med Res Ctr Orthoped & Sports Rehabil Yunnan, Kunming, Peoples R China [5]Clin Med Ctr Spinal Cord Dis Yunnan Prov, Kunming, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Kunming Univ Sci & Technol, Med Coll, Kunming, Peoples R China [2]First Peoples Hosp Yunnan Prov, Dept Orthoped, Kunming, Peoples R China [3]Key Lab Digital Orthoped Yunnan Prov, Kunming, Peoples R China [4]Clin Med Res Ctr Orthoped & Sports Rehabil Yunnan, Kunming, Peoples R China [5]Clin Med Ctr Spinal Cord Dis Yunnan Prov, Kunming, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:98315 今日访问量:0 总访问量:858 更新日期:2025-10-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号 ICP备案:滇ICP备15003244号